Facing the evidence: antidepressant treatment in children and adolescents

Garland, E. Jane
February 2004
CMAJ: Canadian Medical Association Journal;2/17/2004, Vol. 170 Issue 4, p489
Academic Journal
Discusses the nature of antidepressant treatment in children and adolescents. Nature of depression in childhood and adolescence; Characterization of the selective serotonin reuptake inhibitors therapy for young people with depression; Adverse effects of antidepressants on young patients.


Related Articles

  • Desvenlafaxine.  // AHFS Consumer Medication Information;Oct2017, p1 

    Desvenlafaxine is used to treat depression. Desvenlafaxine is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by increasing the amounts of serotonin and norepinephrine, natural substances in the brain that help maintain mental balance.

  • Treatment of Childhood and Adolescent Depression. Clark, Molly S.; Jansen, Kate L.; Cloy, J. Anthony // American Family Physician;9/1/2012, Vol. 86 Issue 5, p442 

    Major depressive disorder in children and adolescents is a common condition that affects physical, emotional, and social development. Risk factors include a family history of depression, parental conflict, poor peer relationships, deficits in coping skills, and negative thinking. Diagnostic...

  • Psychological therapy must accompany antidepressants in young people. Mayor, Susan // BMJ: British Medical Journal (International Edition);10/1/2005, Vol. 331 Issue 7519, p714 

    Offers a look at a clinical guideline on antidepressants in young people. Report that antidepressants should be considered for treating children or young people with depression only in combination with concurrent psychological therapy and with monitoring for side effects; Report that fluoxetine...

  • How do we Safely Treat Depression in Children, Adolescents and Young Adults? Jureidini, Jon // Drug Safety;2009, Vol. 32 Issue 4, p275 

    Increasing concerns about the safety and efficacy of antidepressant drugs for children, adolescents and young adults have been count~red by claims that reduced prescribing of antidepressants may have dangerous consequences. This leaves clinicians unsure as to how to weigh up the evidence and...

  • DEPRESSION DRUGS FOR KIDS: HOW SAFE?  // Time;2/2/2004, Vol. 163 Issue 5, p78 

    Reports on the controversy among medical professionals about whether it is safe to give drugs known as selective serotonin-reuptake inhibitors (SSRIs) to depressed children and teenagers. Warning by British health care officials that doctors should avoid giving any SSRI but Prozac to children,...

  • A Review of Escitalopram and Citalopram in Child and Adolescent Depression. Carandang, Carlo; Jabbal, Rekha; MacBride, Angela; Elbe, Dean // Journal of the Canadian Academy of Child & Adolescent Psychiatry;2011, Vol. 20 Issue 4, p315 

    Objective: To review the basic pharmacology and published literature regarding escitalopram and citalopram in child and adolescent depression. Methods: A literature review was conducted using the search terms: 'escitalopram', 'citalopram', 'depression', 'randomized controlled trial', 'open label...

  • Antidepressants and Alternative Approaches to Helping Children and Adolescents Struggling With Depression. Johnson, Thomas B. // Ethical Human Psychology & Psychiatry;2010, Vol. 12 Issue 3, p238 

    This article develops the thesis that feelings of unhappiness and depression are an inherent and unavoidable part of being alive. Depression should not necessarily be seen as a medical illness or as a type of mental illness. Of course, frequently occurring feelings of depression that create...

  • Tricyclic antidepressants in children and adolescents.  // American Family Physician;9/1/1995, Vol. 52 Issue 3, p1005 

    Presents an abstract from the April 8, 1995 issue of `BMJ,' regarding the adverse effects of tricyclic antidepressant treatment for children and adolescents.

  • Should young people be given antidepressants? NO. Timimi, Sami // BMJ: British Medical Journal (International Edition);10/13/2007, Vol. 335 Issue 7623, p751 

    The author suggests that the medical profession approved the use of selective serotonin reuptake inhibitors before large studies concerning their use in children were completed. The article mentions that evidence indicates that these antidepressants are not effective in young people, can...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics